scholarly article | Q13442814 |
P356 | DOI | 10.1107/S0108270112048573 |
P8608 | Fatcat ID | release_w7m44qxa6jfh5p7xpro5btwswe |
P698 | PubMed publication ID | 23282925 |
P2093 | author name string | Maria Teresa Garland | |
Ricardo Baggio | |||
Carlos Bustos | |||
Fernando Diaz-Marín | |||
Luis Alvarez Thon | |||
P2860 | cites work | A short history of SHELX | Q25938995 |
The Cambridge Structural Database: a quarter of a million crystal structures and rising | Q29039683 | ||
Structure validation in chemical crystallography | Q30485654 | ||
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design | Q31145317 | ||
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). | Q34424619 | ||
Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction | Q56067856 | ||
Fluorine–Fluorine Interactions in the Solid State: An Experimental and Theoretical Study | Q58486660 | ||
P433 | issue | Pt 1 | |
P304 | page(s) | 101-104 | |
P577 | publication date | 2012-12-18 | |
P1433 | published in | Acta Crystallographica Section C: Crystal Structure Communications | Q15708687 |
P1476 | title | 3,5-Dimethyl-4-[(E)-(2-nitrophenyl)diazenyl]-1-(2,3,4,5,6-pentafluorophenyl)-1H-pyrazole | |
P478 | volume | 69 |